The Inscripta® Blog
July 8, 2022
Deep mutational scanning of essential bacterial proteins can guide antibiotic development
It is estimated that nearly 5 million patients who die annually have at least one antimicrobial-resistant infection and these infections…
February 8, 2022
"Digital Genome Engineering: Unlocking the Potential of Synthetic Biology" Symposium Highlights
Inscripta partnered with Build With Biology to put on a half-day virtual symposium “Digital Genome Engineering: Unlocking the Potential of…
January 18, 2022
Ginkgo Bioworks Incorporates the Onyx® platform into its foundries
Ginkgo Bioworks, the leading horizontal platform for cell programming, has recently adopted the Onyx platform into its foundries. The company…
January 11, 2022
What Makes CRISPR Like a Movie Star? SynBioBeta podcast with Nandini Krishnamurthy
Nandini Krishnamurthy, Inscripta’s VP of Microbial Business, appeared as a guest on SynBioBeta’s Built with Biology podcast. The new podcast…
September 28, 2021
Inscripta Technology Helps Scientists Find Targets of Osmotic Stress Tolerance in the E. coli Genome
Scientists have studied osmotic stress in different contexts for many years to understand topics such as how climate change can affect both…
August 24, 2021
In New Publications, Scientists Report Use of MAD7™ Nuclease for Plant Editing and More
A key part of Inscripta’s mission is making genome engineering more accessible. To that end, we released the MAD7™ nuclease sequence for…
August 17, 2021
New Market Report Highlights Opportunity in Synthetic Biology Field
A recent industry report released by the equity research team at William Blair offers a great view of the synthetic biology market — both its…
August 3, 2021
Introducing BioCantor, a Python Library to Navigate Data Coordinate Systems
We’re excited to release a new tool designed by Inscripta’s scientists to help bioinformaticians and genomic scientists work more easily with…
June 29, 2021
Are You Looking for a Role in the Genome Engineering Revolution?
As we continue development of a unique genome engineering platform that we believe will transform what’s possible in biology, another amazing…